As of Wednesday, November 26, Mesoblast Limited’s MESO share price has surged by 10.21%, which has investors questioning if ...
Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback